The Food and Drug Administration gave emergency-use authorization to hydroxychloroquine as a treatment for the coronavirus pandemic on Sunday. But demand for the drug backed by President Donald Trump that is typically used to treat malaria soared prior to the move, according to data from Symphony Health.
Weekly prescriptions soared from 100k to 300k over the past week, since President Trump first mentioned the drug as one of two commons drugs that produced potentially wondrous results if administered together (the other drug, azythromycin, better known as a Z-pak) to COVID-19 patients.
Given the market's desperation for anything that might cure a disease that is killing 1 in 10 people it infects in certain areas, it would seem that concerns of those who took these medications regularly before the crisis might be struggling to source their medication for the first time.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
Just what the big pharm companies planned.
ReplyDeleteThank God and may this country make changes ASAP to put back real labs in this country that follow viruses and have supplies in this country before we closed everything down and decided to let China have it all because they thought it would be more price effective for us. We have depended since 1952 on other countries for real labs and things this country used to have not just dispense medicine but actually work at protecting our country against viruses and diseases that can resurface and slam us with pandemics like this one. We need to be like this country use to be #1 and not a follower but a leader in this nation like we used to be. This also includes making the best medical supplies here in excess than being caught short with not enough to protect us.
ReplyDeleteBring this stuff on! As in NOW!!
ReplyDelete